Check Your Claims Before Reviewers Do

Visual summary (public metrics & output)

Data source: OpenAlex author aggregation listing 30 works and counts by year (h-index 14, cited_by_count ~1364) — visualizes author productivity over time and the recent active years 2018–2026.

Publication & topical strengths (evidence)

• Core topics: RNA biology (AU-rich element regulation, KSRP, mRNA stability), long noncoding RNAs (lncRNAs) and cancer/metastasis, autophagy regulation (Beclin 1), and transcript annotation/genomics — supported by reviews and experimental papers where Dhamija appears as first, middle and last author across journals (PLoS Genetics, JBC, Int J Cancer, Frontiers, Nature Cell Biology).
• Representative high-impact works: Beclin 1 autophagy review (Frontiers) and lncRNA–metastasis review (Int J Cancer), plus experimental articles on ARE-dependent translation and KSRP regulation in JBC/PLoS Genetics demonstrating both mechanistic and translational expertise.

Key citations for these claims are provided below.

Recent work & novel contributions (example)

The new 2026 genome-wide reannotation preprint reports ~4,387 bifunctional genes (~10% of transcribed genes), extensive ORF predictions, circRNA associations, and a public database — indicating strong recent activity in transcriptomics/genome annotation domains where Dhamija is a co-author.

Strengths — evidence-based

• Interdisciplinary depth: co-authorship across molecular mechanism papers, genome-scale analyses, and reviews shows both experimental and conceptual breadth (mRNA regulation, lncRNA biology, autophagy, and genomics).
• Impactful reviews and experimental contributions: several papers have high citation counts (hundreds) indicating community uptake and influence in those subfields.
• Reproducibility orientation: recent genomic study provides data, analysis scripts, and an online database (good open-science practices).

Limitations, blindspots & biases

• Authorship heterogeneity: roles vary from first to last to middle author — careful assessment must separate leadership (first/last) from collaborative contributions.
• Experimental validation gap: the 2026 bifunctional paper relies heavily on computational annotation and ORF prediction; only limited RT-qPCR and limited proteomic/ribosome profiling validation are provided, so functional claims about translation or regulatory roles need more direct evidence (MS, ribo-seq, loss/gain-of-function assays).
• Annotation & detection biases: reliance on transcript catalogs and circRNA databases can over-call bifunctionality where low-expression transcripts or erroneous annotations exist; orthology mapping across assemblies has known gaps that can affect conservation estimates.
• Metrics caveat: citation counts and h-index are informative but can be inflated by a few highly-cited reviews; evaluate per-paper contribution and experimental rigor rather than metrics alone.

Practical recommendations for strengthening future work

1. Increase orthogonal experimental validation for predicted microproteins (targeted mass spectrometry, ribosome profiling) and for ceRNA activity (reporter assays, miRNA perturbation).
2. Clarify authorship contributions in multi-author genomics papers (lead analysis, wet-lab validation, supervision) to better assign scientific leadership.
3. Where possible, include quantitative effect-size estimates and cross-platform validation (independent datasets) to reduce annotation bias.

Concluding evaluation (evidence-weighted)

Sonam Dhamija demonstrates solid, domain-relevant expertise in RNA biology and transcriptomics with a mix of experimental and review papers that have achieved reasonable community impact; the author shows a trajectory toward large-scale genomics annotation work, but novel computational predictions need broader experimental validation to firmly establish functional claims. Metrics (works_count ~30, cited_by_count ~1364, h-index 14) support a mid-career researcher with both mechanistic and bioinformatics skills.

Primary citation evidence used for this review:

• Beclin1 autophagy review
• lncRNA metastasis review
• ARE translation experimental paper
• 2026 bifunctional genes paper

Next actions

If you want, I can (pick one):

• Produce a per-paper contribution map (first/last/middle authorship) and citation-normalized influence graph for Sonam Dhamija.
• Run targeted checks for proteomic/ribosome profiling evidence for top predicted microproteins in the 2026 bifunctional genes dataset.

Create contribution map Validate microproteins